Search results

Search market news

20 stories
quartr

CA: H1 2026 delivered earnings growth, margin expansion, and confirmed 2026 targets

Earnings grew in H1 2026, led by France, Spain, and Brazil, with ROI up 4% and adjusted EPS up 18.3%. Net debt fell by €1.1bn, and 2026 financial targets were confirmed amid strong progress on the Carrefour 2030 plan.Original document: Carrefour SA [CA] Earnings Release — Jul. 23 2026This is an AI…

Quartr en_IN
StocksFR
quartr

COL: EPRA earnings up 4% to €111m, rental income up 5%, and occupancy at 94%

EPRA earnings rose 4% to €111m, with recurring EPS of €17.78cts and rental income up 5% to €207m. Occupancy improved to 94%, disposals exceeded targets, and a strategic Berlin acquisition was completed, while liquidity and credit ratings remain strong.Original document: Colonial SFL SOCIMI SA [COL…

Quartr en_IN
StocksES
bravenewcoin

Uranium Price Stabilizes Near $86 as Cameco Signals an Early Reversal

The momentum indications are slowly improving, though uranium has failed to make a move beyond nearby resistance. Meanwhile, Cameco shares have gained ground on an early opening after bouncing off support of $85-$87 price levels.Uranium Price Holds Above the $85 AreaThe value of uranium at press ti…

Brave New Coin en_IN
FuturesStocksCA
trading-economics

European Stocks Fall Sharply

European stocks closed sharply lower on Thursday, as the surge in energy prices risked higher interest rates in the Eurozone, while markets parsed a series of earnings results.The Euro STOXX 50 fell 1.7% to 6,210 and the STOXX Europe 600 dropped 1.3% to 638.UniCredit sank 4.8% despite posting resul…

Trading Economics en_IN
index
baystreet

Is Telus Stock a Good Buy at $14?

The Canadian telecommunications sector has faced significant headwinds recently, and Telus TSX:TNYSE:TU is a prime example of that. The stock is currently down 19% this year, a sharp decline that has frustrated many long-term shareholders, especially with its losses over the past five years now get…

BayStreet en_IN
StocksCA

Nuvectis' NXP100 Just Achieved the First Marketing Approval Ever for a Once-Daily Oral Factor B Inhibitor

WSW, NY, July 23rd, 2026, FinanceWireNuvectis Pharma NASDAQ:NVCT announced this morning that ciprocopan (NXP100) has been approved by China's National Medical Products Administration (NMPA) for the treatment of adult patients with paroxysmal nocturnal hemoglobinuria (PNH) who have not previously re…

FinanceWire en_IN
StocksCN
modular_finance

Holding(s) in Company

TR-1: Standard form for notification of major holdings1. Issuer DetailsISINGB00BPCT7534Issuer NameCAPITA PLCUK or Non-UK IssuerUK2. Reason for NotificationAn acquisition or disposal of voting rights3. Details of person subject to the notification obligationNameJPMorgan Chase & Co.City of registered…

MFN by Modular Finance en_IN
StocksGB